Hypertrophic cardiomyopathy surgical treatment: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
m (#REDIRECT)
 
Line 1: Line 1:
{{Hypertrophic cardiomyopathy}}
#REDIRECT [[Hypertrophic cardiomyopathy surgery]]
 
'''Editors-In-Chief:''' C. Michael Gibson, M.S., M.D. [mailto:mgibson@perfuse.org], Cafer Zorkun, M.D. [mailto:zorkun@perfuse.org], Caitlin J. Harrigan [mailto:charrigan@perfuse.org], Martin S. Maron, M.D., and Barry J. Maron, M.D.
 
==Cardiac transplantation==
Cardiac transplantation can be performed in patients with HOCM and has been associated with better post-operative survival than those patients transplanted for ischemic cardiomyopathy <ref> Martin S. Maron;  Benjamin M. Kalsmith;  James E. Udelson;  Wenjun Li and  David Denofrio.Survival Following Cardiac Transplantation in Patients with Hypertrophic Cardiomyopathy.doi: 10.1161/CIRCHEARTFAILURE.109.922872</ref>.
 
In cases that are refractory to all other forms of treatment, [[heart transplant|cardiac transplantation]] is an option.
 
==References==
{{reflist|2}}
 
[[Category: Cardiology]]
[[Cstegory:Cardiomyopathy]]
[[Category:Disease]]
{{WH}}
 
{{WS}}

Latest revision as of 17:04, 11 February 2012